Investment House LLC Indaptus Therapeutics, Inc. Transaction History

Investment House LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$0.55 - $0.98 $15,771 - $28,101	28,675 Added 28.62%	128,851 $70,000
Q4 2024 Feb 10, 2025	BUY	$0.84 - $1.77 $168 - $354	200 Added 0.2%	100,176 $85,000
Q3 2024 Nov 07, 2024	SELL	$1.13 - $2.25 $2,780 - $5,537	-2,461 Reduced 2.4%	99,976 $123,000
Q4 2023 Feb 05, 2024	SELL	$1.75 - $2.75 $721 - $1,133	-412 Reduced 0.4%	102,437 $180,000
Q3 2023 Nov 09, 2023	SELL	$1.75 - $3.95 $9,507 - $21,460	-5,433 Reduced 5.02%	102,849 $282,000
Q2 2023 Aug 08, 2023	BUY	$1.6 - $3.04 $20,244 - $38,465	12,653 Added 13.23%	108,282 $206,000
Q4 2021 Feb 09, 2022	BUY	$5.21 - $7.93 $364,574 - $554,909	69,976 Added 272.78%	95,629 $545,000
Q3 2021 Nov 12, 2021	BUY	$7.07 - $14.84 $181,366 - $380,690	25,653 New	25,653 $201,000

43.9K

Ticker INDP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,258,600
Market Cap $68.1M
Description
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

Stay updated on Investment House LLC with notifications on news.